Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG in Colorectal Cancer Patients With Curative Resections
NCT02891538Phase 1Completed
- Sponsor
- UT Health San Antonio
- Start
- Jan 2017
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in colorectal cancer (CRC) comparing epigallocatechin gallate (EGCG) with Observation Only (2 arms). Primary endpoint: Change in methylation from baseline at 1 year. Started Jan 2017; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02891538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02891538.